PULMOCIDE LIMITED

PULMOCIDE LIMITED

PULMOCIDE LIMITED

Pulmocide is focused on the development of inhaled medicines for the treatmentof viral and fungal infections of the respiratory tract.
Type
B2c
Founded
2013
Raised
$58M
Follow us
Alexa global traffic share
Latest funding
$27,541,217
Venture capital (Series A) - 2013
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when PULMOCIDE LIMITED makes some noise.